Now on Pharmaceutical Processing
Using Strategic Flexibility to Succeed in Emerging Pharmaceutical... Comments

Subscribe to Pharmaceutical Processing
 








Digital Library




























 
Industry News
 
April 2009

X-Ray Inspection System Designed For Quality Control In A HACCP Plan
 
February 2009

Amylin Shares Rise As Icahn Raises Stake

Bayer Schering Pharma To Open Beijing R&D Center

Biogen Idec 4Q Profit Grew 3 %

Bristol-Myers Stock Jumps On Takeover Speculation

Cephalon Linked To Indicted Kansas Doctor

Debate On North Dakota Pharmacy Bill Takes On Edge

Dr. D. Gary Gilliland, Internationally-Recognized Physician and Researcher, Joins Merck Research Labs as Head of Oncology Research

Drug Maker Sentenced For Illegal Imports

FDA Approves Clinical Studies Of A Novel Anti-Cancer Drug Developed By Italian Researchers

FDA Approves KAPIDEX Delayed Release Capsules For The Treatment Of GERD

FDA Approves ULORIC(R) (febuxostat) for the Chronic Management of Hyperuricemia in Patients With Gout

FDA Delays Decision On J&J Drug For Mood Disorder

FDA Extends Review Time For Gout Drug

FDA Probes Lilly Blood-Poisoning Treatment

FDA Reviewing Lilly’s Blood Thinner Prasurgel

FDA Seeks Plans To Reduce Misuse Of Painkillers

Federal Trade Commission Files Complaint Against Par Pharmaceutical Over Court-Approved AndroGel(R) Litigation Settlement

Galderma Wins FDA Approval for Vectical Ointment, a Novel Topical Therapy for Psoriasis

Germany's Merck Reports 4Q Loss Of euro279.5 Million

GlaxoSmithKline 4Q Profit Falls, Confirms Job Cuts

GTx's Bone Fracture Drug Under FDA Review

Headline Unavailable

Huge Study Boosts Disappointment On Multivitamins

Human Genome Sciences Begins Delivery of First-in-Class Anthrax Treatment to U.S. Strategic National Stockpile

Ireland's Elan Trims Losses As MS Drug Sales Surge

J&J Seeks Full FDA Approval For HIV Treatment

KV Pharmaceutical Company Reduces Workforce

La Jolla And BioMarin Stop Riquent Trial

MDRNA, Inc. Announces Licensing Agreement With Roche

Merck Will Buy Insmed Biosimilars For $130 million

Novartis May Pay More Than $575M For Blood Thinner

Novogen To Focus On Oncology Program

Official: Sebelius Near Top For Health Post

Oregon Attorney General: Bayer Settling Ad Case For $20 Million

Pfizer Cancer Drug Gets Nod In UK Recommendation

Pfizer Discontinues Global Phase III Trial of Axitinib for Futility in Advanced Pancreatic Cancer

Pfizer To Disclose Payments To Doctors Next Year

Prasugrel Receives Unanimous Approval Recommendation From FDA Advisory Committee

Report: Extavia's Launch Foreshadows Novartis' Future Intentions in the Multiple Sclerosis Market

Report: Glaxo To Cut Prices For Poor Countries

Reports: GlaxoSmithKline To Cut Thousands Of Jobs

Roche CEO: Offer For Genentech A Fair Deal

Roche Launches $86.50-A-Share Bid For Genentech

Roche Says Full-Year Net Income Down 5 Percent

Sandoz Accused By Alabama Of Overpricing

Sanofi Pasteur Dengue Vaccine Enters Pediatric Efficacy Clinical Study

Sanofi-aventis 4Q Profit Sinks 76% On Charge

Sanofi-aventis Appoints Jean-Pierre Lehner Chief Medical Officer

Schering-Plough Swings To 4Q Profit

Trial To Begin In Lawsuit Against Drug Company

USP Proposes Strengthened Partnership With HHS, FDA, To Help Protect Patients and Consumers

Vical Reports Positive Bird Flu Vaccine Trial Data

Warner Chilcott Announces Agreement to Acquire Topical Alprostadil Treatment for Erectile Dysfunction

Wisconsin Attorney General Hails Major Victory Against Pfizer Unit

Wyeth Deal Could Mean NJ Drug Industry Job Cuts


 
Small Doses

Dear Santa...

by Mike Auerbach, Editor
Mike Auerbach, Editor Pharmaceutical Processing
Ok - yes - I'm too old to believe in Santa. But that won't stop me from putting together my own wish list.
You see, we are at interesting place in time. Not only is 2009 ending, but the first decade of the new century is also coming to a close. Is there a better time than now to look back at the first 10 years of the '00s, or the "aughts", or whatever clever term historians might use to put a label on this decade, and make a wish list for the next ten years?

In retrospect we should have known 10 years ago, we were in for some "interesting times" as the often-quoted Chinese proverb states, when the 2000 presidential election hung in the balance and was basically decided on the interpretation of what a "hanging chad" is.

So, without further ado, here is my wish list for the next ten years. Some "pie in the sky"- some more down to earth:

• Health and happiness for my family and friends.
Has to be the first one on my list - no apologies for this one.

• Cures and/or better treatments for all types of cancers.
I've seen way too much of this over the last ten years - can we finally eradicate this curse?

• Healthcare coverage that is affordable, accessible and understandable
Who could sift through a 2,000 page document and really understand it - much less vote on it?

• More investment and research into "real" diseases.
Sorry, hair loss and male enhancement products don't count as "real".

• Less stress about the economy, jobs, the environment, etc.
Is this possible? I sure hope so.

• Less hate, fewer wars and more tolerance.
Come on - can't we all get along?

That's it - that's all I'm asking for. I'm not sure if Santa will read this - but I think Santa follows me on Twitter.

More Small Doses






























Bioscience Technology Chromatography Techniques Drug Discovery & Development Laboratory Equipment Pharmaceutical Processing R&D Scientific Computing
Advantage Business Media © Copyright 2010 Advantage Business Media
Privacy Policy | Terms & Conditions | Advertise With Us